nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—ABCB1—colon cancer	0.267	1	CbGaD
Omeprazole—ABCC3—Fluorouracil—colon cancer	0.103	0.191	CbGbCtD
Omeprazole—ABCC3—Vincristine—colon cancer	0.0937	0.174	CbGbCtD
Omeprazole—ABCC3—Methotrexate—colon cancer	0.0568	0.105	CbGbCtD
Omeprazole—ABCG2—Irinotecan—colon cancer	0.0441	0.0816	CbGbCtD
Omeprazole—ABCG2—Fluorouracil—colon cancer	0.0423	0.0784	CbGbCtD
Omeprazole—ABCG2—Vincristine—colon cancer	0.0385	0.0714	CbGbCtD
Omeprazole—CYP2C9—Capecitabine—colon cancer	0.0265	0.0491	CbGbCtD
Omeprazole—ABCG2—Methotrexate—colon cancer	0.0233	0.0432	CbGbCtD
Omeprazole—CYP2C8—Fluorouracil—colon cancer	0.0225	0.0417	CbGbCtD
Omeprazole—CYP1A2—Fluorouracil—colon cancer	0.0174	0.0323	CbGbCtD
Omeprazole—ABCB1—Irinotecan—colon cancer	0.0159	0.0294	CbGbCtD
Omeprazole—CYP2C9—Fluorouracil—colon cancer	0.0157	0.0291	CbGbCtD
Omeprazole—ABCB1—Vincristine—colon cancer	0.0139	0.0257	CbGbCtD
Omeprazole—CYP3A4—Irinotecan—colon cancer	0.00952	0.0176	CbGbCtD
Omeprazole—ABCB1—Methotrexate—colon cancer	0.00841	0.0156	CbGbCtD
Omeprazole—CYP3A4—Vincristine—colon cancer	0.00832	0.0154	CbGbCtD
Omeprazole—ATP4B—digestive system—colon cancer	0.00325	0.0925	CbGeAlD
Omeprazole—ATP4B—liver—colon cancer	0.00242	0.0689	CbGeAlD
Omeprazole—ATP4A—epithelium—colon cancer	0.00186	0.0529	CbGeAlD
Omeprazole—ABCC3—gall bladder—colon cancer	0.00183	0.0521	CbGeAlD
Omeprazole—ATP4A—renal system—colon cancer	0.00173	0.0491	CbGeAlD
Omeprazole—ATP4A—digestive system—colon cancer	0.00142	0.0403	CbGeAlD
Omeprazole—CYP2C18—digestive system—colon cancer	0.00116	0.0331	CbGeAlD
Omeprazole—ATP4A—liver—colon cancer	0.00106	0.03	CbGeAlD
Omeprazole—CYP2C18—vagina—colon cancer	0.00103	0.0292	CbGeAlD
Omeprazole—ABCC3—renal system—colon cancer	0.000878	0.025	CbGeAlD
Omeprazole—CYP2C18—liver—colon cancer	0.000867	0.0247	CbGeAlD
Omeprazole—ABCC3—digestive system—colon cancer	0.00072	0.0205	CbGeAlD
Omeprazole—CYP1B1—smooth muscle tissue—colon cancer	0.000714	0.0203	CbGeAlD
Omeprazole—CYP1B1—renal system—colon cancer	0.000687	0.0195	CbGeAlD
Omeprazole—Pantoprazole—ABCB1—colon cancer	0.000681	0.573	CrCbGaD
Omeprazole—CYP1B1—lymphoid tissue—colon cancer	0.000571	0.0162	CbGeAlD
Omeprazole—CYP1B1—digestive system—colon cancer	0.000564	0.016	CbGeAlD
Omeprazole—ABCB1—blood vessel—colon cancer	0.000559	0.0159	CbGeAlD
Omeprazole—ABCC3—liver—colon cancer	0.000537	0.0153	CbGeAlD
Omeprazole—CYP11A1—lymph node—colon cancer	0.00053	0.0151	CbGeAlD
Omeprazole—CYP2C8—renal system—colon cancer	0.000526	0.015	CbGeAlD
Omeprazole—CYP1A1—epithelium—colon cancer	0.000524	0.0149	CbGeAlD
Omeprazole—Lansoprazole—ABCB1—colon cancer	0.000507	0.427	CrCbGaD
Omeprazole—CYP2C19—digestive system—colon cancer	0.000495	0.0141	CbGeAlD
Omeprazole—CYP1A2—renal system—colon cancer	0.000493	0.014	CbGeAlD
Omeprazole—CYP1A1—renal system—colon cancer	0.000486	0.0138	CbGeAlD
Omeprazole—CYP2C19—vagina—colon cancer	0.000437	0.0124	CbGeAlD
Omeprazole—CYP1B1—liver—colon cancer	0.00042	0.0119	CbGeAlD
Omeprazole—ABCC3—lymph node—colon cancer	0.000412	0.0117	CbGeAlD
Omeprazole—CYP1A2—digestive system—colon cancer	0.000404	0.0115	CbGeAlD
Omeprazole—CYP1A1—digestive system—colon cancer	0.000399	0.0113	CbGeAlD
Omeprazole—ABCG2—bone marrow—colon cancer	0.000387	0.011	CbGeAlD
Omeprazole—CYP2C9—digestive system—colon cancer	0.000384	0.0109	CbGeAlD
Omeprazole—CYP2C8—vagina—colon cancer	0.000381	0.0108	CbGeAlD
Omeprazole—ABCG2—vagina—colon cancer	0.000371	0.0105	CbGeAlD
Omeprazole—CYP2C19—liver—colon cancer	0.000369	0.0105	CbGeAlD
Omeprazole—CYP3A4—renal system—colon cancer	0.000357	0.0101	CbGeAlD
Omeprazole—CYP1A1—vagina—colon cancer	0.000352	0.01	CbGeAlD
Omeprazole—CYP2D6—renal system—colon cancer	0.000351	0.00998	CbGeAlD
Omeprazole—ABCB1—embryo—colon cancer	0.000333	0.00948	CbGeAlD
Omeprazole—CYP1B1—lymph node—colon cancer	0.000322	0.00916	CbGeAlD
Omeprazole—CYP2C8—liver—colon cancer	0.000322	0.00915	CbGeAlD
Omeprazole—ABCG2—liver—colon cancer	0.000313	0.00889	CbGeAlD
Omeprazole—CYP1A2—liver—colon cancer	0.000301	0.00856	CbGeAlD
Omeprazole—CYP1A1—liver—colon cancer	0.000297	0.00844	CbGeAlD
Omeprazole—CYP3A4—digestive system—colon cancer	0.000292	0.00832	CbGeAlD
Omeprazole—CYP2D6—digestive system—colon cancer	0.000288	0.00818	CbGeAlD
Omeprazole—CYP2C9—liver—colon cancer	0.000286	0.00812	CbGeAlD
Omeprazole—ABCB1—epithelium—colon cancer	0.000272	0.00774	CbGeAlD
Omeprazole—ABCB1—renal system—colon cancer	0.000252	0.00718	CbGeAlD
Omeprazole—ABCG2—lymph node—colon cancer	0.00024	0.00682	CbGeAlD
Omeprazole—CYP1A1—lymph node—colon cancer	0.000228	0.00647	CbGeAlD
Omeprazole—CYP3A4—liver—colon cancer	0.000218	0.0062	CbGeAlD
Omeprazole—CYP2D6—liver—colon cancer	0.000214	0.0061	CbGeAlD
Omeprazole—ABCB1—lymphoid tissue—colon cancer	0.00021	0.00596	CbGeAlD
Omeprazole—ABCB1—digestive system—colon cancer	0.000207	0.00589	CbGeAlD
Omeprazole—Urinary tract infection—Capecitabine—colon cancer	0.000206	0.00148	CcSEcCtD
Omeprazole—Osteoarthritis—Methotrexate—colon cancer	0.000204	0.00147	CcSEcCtD
Omeprazole—Confusional state—Irinotecan—colon cancer	0.000203	0.00146	CcSEcCtD
Omeprazole—Nervous system disorder—Vincristine—colon cancer	0.000203	0.00146	CcSEcCtD
Omeprazole—Thrombocytopenia—Vincristine—colon cancer	0.000203	0.00146	CcSEcCtD
Omeprazole—Haematuria—Capecitabine—colon cancer	0.000202	0.00145	CcSEcCtD
Omeprazole—Anaphylactic shock—Irinotecan—colon cancer	0.000202	0.00145	CcSEcCtD
Omeprazole—Myalgia—Fluorouracil—colon cancer	0.000201	0.00145	CcSEcCtD
Omeprazole—Chest pain—Fluorouracil—colon cancer	0.000201	0.00145	CcSEcCtD
Omeprazole—Infection—Irinotecan—colon cancer	0.0002	0.00144	CcSEcCtD
Omeprazole—Hyperhidrosis—Vincristine—colon cancer	0.0002	0.00144	CcSEcCtD
Omeprazole—Hepatobiliary disease—Capecitabine—colon cancer	0.0002	0.00144	CcSEcCtD
Omeprazole—Epistaxis—Capecitabine—colon cancer	0.0002	0.00144	CcSEcCtD
Omeprazole—Discomfort—Fluorouracil—colon cancer	0.000199	0.00143	CcSEcCtD
Omeprazole—Shock—Irinotecan—colon cancer	0.000198	0.00143	CcSEcCtD
Omeprazole—Nervous system disorder—Irinotecan—colon cancer	0.000198	0.00142	CcSEcCtD
Omeprazole—Agranulocytosis—Capecitabine—colon cancer	0.000197	0.00142	CcSEcCtD
Omeprazole—Thrombocytopenia—Irinotecan—colon cancer	0.000197	0.00142	CcSEcCtD
Omeprazole—Anorexia—Vincristine—colon cancer	0.000197	0.00142	CcSEcCtD
Omeprazole—Irritability—Methotrexate—colon cancer	0.000195	0.0014	CcSEcCtD
Omeprazole—Hyperhidrosis—Irinotecan—colon cancer	0.000195	0.0014	CcSEcCtD
Omeprazole—Confusional state—Fluorouracil—colon cancer	0.000195	0.0014	CcSEcCtD
Omeprazole—Bradycardia—Capecitabine—colon cancer	0.000193	0.00139	CcSEcCtD
Omeprazole—Anaphylactic shock—Fluorouracil—colon cancer	0.000193	0.00139	CcSEcCtD
Omeprazole—Anorexia—Irinotecan—colon cancer	0.000192	0.00138	CcSEcCtD
Omeprazole—Infection—Fluorouracil—colon cancer	0.000192	0.00138	CcSEcCtD
Omeprazole—ABCB1—bone marrow—colon cancer	0.000191	0.00543	CbGeAlD
Omeprazole—Rhinitis—Capecitabine—colon cancer	0.00019	0.00137	CcSEcCtD
Omeprazole—Hepatitis—Capecitabine—colon cancer	0.00019	0.00137	CcSEcCtD
Omeprazole—Nervous system disorder—Fluorouracil—colon cancer	0.000189	0.00136	CcSEcCtD
Omeprazole—Thrombocytopenia—Fluorouracil—colon cancer	0.000189	0.00136	CcSEcCtD
Omeprazole—Hypoaesthesia—Capecitabine—colon cancer	0.000189	0.00136	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Vincristine—colon cancer	0.000189	0.00136	CcSEcCtD
Omeprazole—Pharyngitis—Capecitabine—colon cancer	0.000189	0.00136	CcSEcCtD
Omeprazole—Tachycardia—Fluorouracil—colon cancer	0.000189	0.00136	CcSEcCtD
Omeprazole—Urinary tract disorder—Capecitabine—colon cancer	0.000188	0.00135	CcSEcCtD
Omeprazole—Insomnia—Vincristine—colon cancer	0.000187	0.00135	CcSEcCtD
Omeprazole—Oedema peripheral—Capecitabine—colon cancer	0.000187	0.00135	CcSEcCtD
Omeprazole—Connective tissue disorder—Capecitabine—colon cancer	0.000187	0.00134	CcSEcCtD
Omeprazole—Urethral disorder—Capecitabine—colon cancer	0.000186	0.00134	CcSEcCtD
Omeprazole—Paraesthesia—Vincristine—colon cancer	0.000186	0.00134	CcSEcCtD
Omeprazole—Breast disorder—Methotrexate—colon cancer	0.000185	0.00133	CcSEcCtD
Omeprazole—Anorexia—Fluorouracil—colon cancer	0.000184	0.00133	CcSEcCtD
Omeprazole—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000184	0.00133	CcSEcCtD
Omeprazole—Visual impairment—Capecitabine—colon cancer	0.000183	0.00132	CcSEcCtD
Omeprazole—ABCB1—vagina—colon cancer	0.000183	0.0052	CbGeAlD
Omeprazole—Insomnia—Irinotecan—colon cancer	0.000182	0.00131	CcSEcCtD
Omeprazole—Paraesthesia—Irinotecan—colon cancer	0.000181	0.0013	CcSEcCtD
Omeprazole—Decreased appetite—Vincristine—colon cancer	0.00018	0.0013	CcSEcCtD
Omeprazole—Dyspnoea—Irinotecan—colon cancer	0.00018	0.00129	CcSEcCtD
Omeprazole—Erythema multiforme—Capecitabine—colon cancer	0.00018	0.00129	CcSEcCtD
Omeprazole—Somnolence—Irinotecan—colon cancer	0.000179	0.00129	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Vincristine—colon cancer	0.000179	0.00129	CcSEcCtD
Omeprazole—Fatigue—Vincristine—colon cancer	0.000179	0.00129	CcSEcCtD
Omeprazole—Eye disorder—Capecitabine—colon cancer	0.000178	0.00128	CcSEcCtD
Omeprazole—Dyspepsia—Irinotecan—colon cancer	0.000178	0.00128	CcSEcCtD
Omeprazole—Tinnitus—Capecitabine—colon cancer	0.000177	0.00127	CcSEcCtD
Omeprazole—Pain—Vincristine—colon cancer	0.000177	0.00127	CcSEcCtD
Omeprazole—Constipation—Vincristine—colon cancer	0.000177	0.00127	CcSEcCtD
Omeprazole—Asthma—Methotrexate—colon cancer	0.000177	0.00127	CcSEcCtD
Omeprazole—Flushing—Capecitabine—colon cancer	0.000176	0.00127	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000176	0.00127	CcSEcCtD
Omeprazole—Decreased appetite—Irinotecan—colon cancer	0.000175	0.00126	CcSEcCtD
Omeprazole—Insomnia—Fluorouracil—colon cancer	0.000175	0.00126	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Irinotecan—colon cancer	0.000174	0.00125	CcSEcCtD
Omeprazole—Fatigue—Irinotecan—colon cancer	0.000174	0.00125	CcSEcCtD
Omeprazole—Paraesthesia—Fluorouracil—colon cancer	0.000173	0.00125	CcSEcCtD
Omeprazole—Pancreatitis—Methotrexate—colon cancer	0.000173	0.00125	CcSEcCtD
Omeprazole—Pain—Irinotecan—colon cancer	0.000172	0.00124	CcSEcCtD
Omeprazole—Constipation—Irinotecan—colon cancer	0.000172	0.00124	CcSEcCtD
Omeprazole—Dyspnoea—Fluorouracil—colon cancer	0.000172	0.00124	CcSEcCtD
Omeprazole—Somnolence—Fluorouracil—colon cancer	0.000172	0.00124	CcSEcCtD
Omeprazole—Immune system disorder—Capecitabine—colon cancer	0.000172	0.00124	CcSEcCtD
Omeprazole—Mediastinal disorder—Capecitabine—colon cancer	0.000171	0.00123	CcSEcCtD
Omeprazole—Chills—Capecitabine—colon cancer	0.00017	0.00123	CcSEcCtD
Omeprazole—Dyspepsia—Fluorouracil—colon cancer	0.00017	0.00122	CcSEcCtD
Omeprazole—Gastrointestinal pain—Vincristine—colon cancer	0.000169	0.00122	CcSEcCtD
Omeprazole—Decreased appetite—Fluorouracil—colon cancer	0.000168	0.00121	CcSEcCtD
Omeprazole—Alopecia—Capecitabine—colon cancer	0.000168	0.00121	CcSEcCtD
Omeprazole—Pancytopenia—Methotrexate—colon cancer	0.000168	0.00121	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000167	0.0012	CcSEcCtD
Omeprazole—Mental disorder—Capecitabine—colon cancer	0.000166	0.0012	CcSEcCtD
Omeprazole—Feeling abnormal—Irinotecan—colon cancer	0.000166	0.0012	CcSEcCtD
Omeprazole—Malnutrition—Capecitabine—colon cancer	0.000165	0.00119	CcSEcCtD
Omeprazole—Neutropenia—Methotrexate—colon cancer	0.000165	0.00119	CcSEcCtD
Omeprazole—Dysuria—Methotrexate—colon cancer	0.000165	0.00119	CcSEcCtD
Omeprazole—Pain—Fluorouracil—colon cancer	0.000165	0.00119	CcSEcCtD
Omeprazole—Gastrointestinal pain—Irinotecan—colon cancer	0.000165	0.00119	CcSEcCtD
Omeprazole—Upper respiratory tract infection—Methotrexate—colon cancer	0.000164	0.00118	CcSEcCtD
Omeprazole—Body temperature increased—Vincristine—colon cancer	0.000164	0.00118	CcSEcCtD
Omeprazole—Abdominal pain—Vincristine—colon cancer	0.000164	0.00118	CcSEcCtD
Omeprazole—Flatulence—Capecitabine—colon cancer	0.000163	0.00117	CcSEcCtD
Omeprazole—Erectile dysfunction—Methotrexate—colon cancer	0.000163	0.00117	CcSEcCtD
Omeprazole—Dysgeusia—Capecitabine—colon cancer	0.000162	0.00117	CcSEcCtD
Omeprazole—Photosensitivity reaction—Methotrexate—colon cancer	0.000161	0.00116	CcSEcCtD
Omeprazole—Back pain—Capecitabine—colon cancer	0.00016	0.00115	CcSEcCtD
Omeprazole—Abdominal pain—Irinotecan—colon cancer	0.000159	0.00115	CcSEcCtD
Omeprazole—Body temperature increased—Irinotecan—colon cancer	0.000159	0.00115	CcSEcCtD
Omeprazole—Feeling abnormal—Fluorouracil—colon cancer	0.000159	0.00115	CcSEcCtD
Omeprazole—Muscle spasms—Capecitabine—colon cancer	0.000159	0.00114	CcSEcCtD
Omeprazole—Infestation—Methotrexate—colon cancer	0.000158	0.00113	CcSEcCtD
Omeprazole—Infestation NOS—Methotrexate—colon cancer	0.000158	0.00113	CcSEcCtD
Omeprazole—Depression—Methotrexate—colon cancer	0.000157	0.00113	CcSEcCtD
Omeprazole—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000156	0.00112	CcSEcCtD
Omeprazole—Vision blurred—Capecitabine—colon cancer	0.000156	0.00112	CcSEcCtD
Omeprazole—Tremor—Capecitabine—colon cancer	0.000155	0.00112	CcSEcCtD
Omeprazole—Renal failure—Methotrexate—colon cancer	0.000155	0.00111	CcSEcCtD
Omeprazole—ABCB1—liver—colon cancer	0.000154	0.00439	CbGeAlD
Omeprazole—Stomatitis—Methotrexate—colon cancer	0.000154	0.00111	CcSEcCtD
Omeprazole—Ill-defined disorder—Capecitabine—colon cancer	0.000153	0.0011	CcSEcCtD
Omeprazole—Urticaria—Fluorouracil—colon cancer	0.000153	0.0011	CcSEcCtD
Omeprazole—Conjunctivitis—Methotrexate—colon cancer	0.000153	0.0011	CcSEcCtD
Omeprazole—Anaemia—Capecitabine—colon cancer	0.000153	0.0011	CcSEcCtD
Omeprazole—Body temperature increased—Fluorouracil—colon cancer	0.000153	0.0011	CcSEcCtD
Omeprazole—Hypersensitivity—Vincristine—colon cancer	0.000153	0.0011	CcSEcCtD
Omeprazole—Haematuria—Methotrexate—colon cancer	0.00015	0.00108	CcSEcCtD
Omeprazole—Malaise—Capecitabine—colon cancer	0.000149	0.00107	CcSEcCtD
Omeprazole—Hepatobiliary disease—Methotrexate—colon cancer	0.000149	0.00107	CcSEcCtD
Omeprazole—Epistaxis—Methotrexate—colon cancer	0.000149	0.00107	CcSEcCtD
Omeprazole—Vertigo—Capecitabine—colon cancer	0.000149	0.00107	CcSEcCtD
Omeprazole—Hypersensitivity—Irinotecan—colon cancer	0.000149	0.00107	CcSEcCtD
Omeprazole—Asthenia—Vincristine—colon cancer	0.000149	0.00107	CcSEcCtD
Omeprazole—Leukopenia—Capecitabine—colon cancer	0.000148	0.00107	CcSEcCtD
Omeprazole—Agranulocytosis—Methotrexate—colon cancer	0.000147	0.00106	CcSEcCtD
Omeprazole—Palpitations—Capecitabine—colon cancer	0.000146	0.00105	CcSEcCtD
Omeprazole—Asthenia—Irinotecan—colon cancer	0.000145	0.00104	CcSEcCtD
Omeprazole—Cough—Capecitabine—colon cancer	0.000144	0.00104	CcSEcCtD
Omeprazole—Hypertension—Capecitabine—colon cancer	0.000143	0.00103	CcSEcCtD
Omeprazole—Hypersensitivity—Fluorouracil—colon cancer	0.000142	0.00102	CcSEcCtD
Omeprazole—Diarrhoea—Vincristine—colon cancer	0.000142	0.00102	CcSEcCtD
Omeprazole—Hepatitis—Methotrexate—colon cancer	0.000141	0.00102	CcSEcCtD
Omeprazole—Myalgia—Capecitabine—colon cancer	0.000141	0.00101	CcSEcCtD
Omeprazole—Chest pain—Capecitabine—colon cancer	0.000141	0.00101	CcSEcCtD
Omeprazole—Arthralgia—Capecitabine—colon cancer	0.000141	0.00101	CcSEcCtD
Omeprazole—Pharyngitis—Methotrexate—colon cancer	0.00014	0.00101	CcSEcCtD
Omeprazole—Anxiety—Capecitabine—colon cancer	0.00014	0.00101	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00014	0.00101	CcSEcCtD
Omeprazole—Urinary tract disorder—Methotrexate—colon cancer	0.00014	0.00101	CcSEcCtD
Omeprazole—Discomfort—Capecitabine—colon cancer	0.000139	0.001	CcSEcCtD
Omeprazole—Urethral disorder—Methotrexate—colon cancer	0.000139	0.000998	CcSEcCtD
Omeprazole—Diarrhoea—Irinotecan—colon cancer	0.000138	0.000993	CcSEcCtD
Omeprazole—Dry mouth—Capecitabine—colon cancer	0.000138	0.000991	CcSEcCtD
Omeprazole—Dizziness—Vincristine—colon cancer	0.000137	0.000986	CcSEcCtD
Omeprazole—Pruritus—Fluorouracil—colon cancer	0.000137	0.000984	CcSEcCtD
Omeprazole—Visual impairment—Methotrexate—colon cancer	0.000136	0.000981	CcSEcCtD
Omeprazole—Confusional state—Capecitabine—colon cancer	0.000136	0.00098	CcSEcCtD
Omeprazole—Infection—Capecitabine—colon cancer	0.000134	0.000965	CcSEcCtD
Omeprazole—Erythema multiforme—Methotrexate—colon cancer	0.000134	0.000962	CcSEcCtD
Omeprazole—Dizziness—Irinotecan—colon cancer	0.000133	0.00096	CcSEcCtD
Omeprazole—Shock—Capecitabine—colon cancer	0.000133	0.000956	CcSEcCtD
Omeprazole—Nervous system disorder—Capecitabine—colon cancer	0.000132	0.000953	CcSEcCtD
Omeprazole—Eye disorder—Methotrexate—colon cancer	0.000132	0.000951	CcSEcCtD
Omeprazole—Diarrhoea—Fluorouracil—colon cancer	0.000132	0.000951	CcSEcCtD
Omeprazole—Thrombocytopenia—Capecitabine—colon cancer	0.000132	0.000951	CcSEcCtD
Omeprazole—Tinnitus—Methotrexate—colon cancer	0.000132	0.000949	CcSEcCtD
Omeprazole—Tachycardia—Capecitabine—colon cancer	0.000132	0.000948	CcSEcCtD
Omeprazole—Vomiting—Vincristine—colon cancer	0.000132	0.000948	CcSEcCtD
Omeprazole—Skin disorder—Capecitabine—colon cancer	0.000131	0.000944	CcSEcCtD
Omeprazole—Rash—Vincristine—colon cancer	0.000131	0.00094	CcSEcCtD
Omeprazole—Hyperhidrosis—Capecitabine—colon cancer	0.00013	0.000939	CcSEcCtD
Omeprazole—Dermatitis—Vincristine—colon cancer	0.00013	0.000939	CcSEcCtD
Omeprazole—Headache—Vincristine—colon cancer	0.00013	0.000934	CcSEcCtD
Omeprazole—Anorexia—Capecitabine—colon cancer	0.000129	0.000926	CcSEcCtD
Omeprazole—Vomiting—Irinotecan—colon cancer	0.000128	0.000923	CcSEcCtD
Omeprazole—Immune system disorder—Methotrexate—colon cancer	0.000128	0.000919	CcSEcCtD
Omeprazole—Dizziness—Fluorouracil—colon cancer	0.000128	0.000919	CcSEcCtD
Omeprazole—Mediastinal disorder—Methotrexate—colon cancer	0.000127	0.000917	CcSEcCtD
Omeprazole—Rash—Irinotecan—colon cancer	0.000127	0.000915	CcSEcCtD
Omeprazole—Dermatitis—Irinotecan—colon cancer	0.000127	0.000914	CcSEcCtD
Omeprazole—Chills—Methotrexate—colon cancer	0.000127	0.000913	CcSEcCtD
Omeprazole—Headache—Irinotecan—colon cancer	0.000126	0.000909	CcSEcCtD
Omeprazole—Alopecia—Methotrexate—colon cancer	0.000125	0.0009	CcSEcCtD
Omeprazole—Mental disorder—Methotrexate—colon cancer	0.000124	0.000892	CcSEcCtD
Omeprazole—Malnutrition—Methotrexate—colon cancer	0.000123	0.000886	CcSEcCtD
Omeprazole—Nausea—Vincristine—colon cancer	0.000123	0.000885	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000123	0.000885	CcSEcCtD
Omeprazole—Vomiting—Fluorouracil—colon cancer	0.000123	0.000884	CcSEcCtD
Omeprazole—Insomnia—Capecitabine—colon cancer	0.000122	0.000879	CcSEcCtD
Omeprazole—Rash—Fluorouracil—colon cancer	0.000122	0.000877	CcSEcCtD
Omeprazole—Dermatitis—Fluorouracil—colon cancer	0.000122	0.000876	CcSEcCtD
Omeprazole—Paraesthesia—Capecitabine—colon cancer	0.000121	0.000872	CcSEcCtD
Omeprazole—Headache—Fluorouracil—colon cancer	0.000121	0.000871	CcSEcCtD
Omeprazole—Dysgeusia—Methotrexate—colon cancer	0.000121	0.000868	CcSEcCtD
Omeprazole—Dyspnoea—Capecitabine—colon cancer	0.00012	0.000866	CcSEcCtD
Omeprazole—Nausea—Irinotecan—colon cancer	0.00012	0.000862	CcSEcCtD
Omeprazole—Back pain—Methotrexate—colon cancer	0.000119	0.000857	CcSEcCtD
Omeprazole—Dyspepsia—Capecitabine—colon cancer	0.000119	0.000855	CcSEcCtD
Omeprazole—ABCB1—lymph node—colon cancer	0.000118	0.00336	CbGeAlD
Omeprazole—Decreased appetite—Capecitabine—colon cancer	0.000117	0.000845	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Capecitabine—colon cancer	0.000117	0.000839	CcSEcCtD
Omeprazole—Fatigue—Capecitabine—colon cancer	0.000116	0.000838	CcSEcCtD
Omeprazole—Vision blurred—Methotrexate—colon cancer	0.000116	0.000835	CcSEcCtD
Omeprazole—Pain—Capecitabine—colon cancer	0.000115	0.000831	CcSEcCtD
Omeprazole—Constipation—Capecitabine—colon cancer	0.000115	0.000831	CcSEcCtD
Omeprazole—Nausea—Fluorouracil—colon cancer	0.000115	0.000826	CcSEcCtD
Omeprazole—Ill-defined disorder—Methotrexate—colon cancer	0.000114	0.000822	CcSEcCtD
Omeprazole—Anaemia—Methotrexate—colon cancer	0.000114	0.000819	CcSEcCtD
Omeprazole—Feeling abnormal—Capecitabine—colon cancer	0.000111	0.000801	CcSEcCtD
Omeprazole—Malaise—Methotrexate—colon cancer	0.000111	0.000799	CcSEcCtD
Omeprazole—Vertigo—Methotrexate—colon cancer	0.000111	0.000796	CcSEcCtD
Omeprazole—Gastrointestinal pain—Capecitabine—colon cancer	0.00011	0.000794	CcSEcCtD
Omeprazole—Leukopenia—Methotrexate—colon cancer	0.00011	0.000793	CcSEcCtD
Omeprazole—Cough—Methotrexate—colon cancer	0.000107	0.000773	CcSEcCtD
Omeprazole—Urticaria—Capecitabine—colon cancer	0.000107	0.000772	CcSEcCtD
Omeprazole—Abdominal pain—Capecitabine—colon cancer	0.000107	0.000768	CcSEcCtD
Omeprazole—Body temperature increased—Capecitabine—colon cancer	0.000107	0.000768	CcSEcCtD
Omeprazole—Arthralgia—Methotrexate—colon cancer	0.000105	0.000754	CcSEcCtD
Omeprazole—Chest pain—Methotrexate—colon cancer	0.000105	0.000754	CcSEcCtD
Omeprazole—Myalgia—Methotrexate—colon cancer	0.000105	0.000754	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000104	0.000749	CcSEcCtD
Omeprazole—Discomfort—Methotrexate—colon cancer	0.000104	0.000745	CcSEcCtD
Omeprazole—Confusional state—Methotrexate—colon cancer	0.000101	0.000729	CcSEcCtD
Omeprazole—Anaphylactic shock—Methotrexate—colon cancer	0.0001	0.000723	CcSEcCtD
Omeprazole—Infection—Methotrexate—colon cancer	9.98e-05	0.000718	CcSEcCtD
Omeprazole—Hypersensitivity—Capecitabine—colon cancer	9.94e-05	0.000716	CcSEcCtD
Omeprazole—Nervous system disorder—Methotrexate—colon cancer	9.85e-05	0.000709	CcSEcCtD
Omeprazole—Thrombocytopenia—Methotrexate—colon cancer	9.84e-05	0.000708	CcSEcCtD
Omeprazole—Skin disorder—Methotrexate—colon cancer	9.76e-05	0.000702	CcSEcCtD
Omeprazole—Hyperhidrosis—Methotrexate—colon cancer	9.71e-05	0.000699	CcSEcCtD
Omeprazole—Asthenia—Capecitabine—colon cancer	9.68e-05	0.000697	CcSEcCtD
Omeprazole—Anorexia—Methotrexate—colon cancer	9.58e-05	0.000689	CcSEcCtD
Omeprazole—Pruritus—Capecitabine—colon cancer	9.55e-05	0.000687	CcSEcCtD
Omeprazole—Diarrhoea—Capecitabine—colon cancer	9.24e-05	0.000665	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Methotrexate—colon cancer	9.15e-05	0.000659	CcSEcCtD
Omeprazole—Insomnia—Methotrexate—colon cancer	9.09e-05	0.000654	CcSEcCtD
Omeprazole—Paraesthesia—Methotrexate—colon cancer	9.02e-05	0.000649	CcSEcCtD
Omeprazole—Dyspnoea—Methotrexate—colon cancer	8.96e-05	0.000645	CcSEcCtD
Omeprazole—Somnolence—Methotrexate—colon cancer	8.93e-05	0.000643	CcSEcCtD
Omeprazole—Dizziness—Capecitabine—colon cancer	8.93e-05	0.000642	CcSEcCtD
Omeprazole—Dyspepsia—Methotrexate—colon cancer	8.84e-05	0.000637	CcSEcCtD
Omeprazole—Decreased appetite—Methotrexate—colon cancer	8.73e-05	0.000629	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Methotrexate—colon cancer	8.67e-05	0.000624	CcSEcCtD
Omeprazole—Fatigue—Methotrexate—colon cancer	8.66e-05	0.000624	CcSEcCtD
Omeprazole—Pain—Methotrexate—colon cancer	8.59e-05	0.000618	CcSEcCtD
Omeprazole—Vomiting—Capecitabine—colon cancer	8.58e-05	0.000618	CcSEcCtD
Omeprazole—Rash—Capecitabine—colon cancer	8.51e-05	0.000613	CcSEcCtD
Omeprazole—Dermatitis—Capecitabine—colon cancer	8.5e-05	0.000612	CcSEcCtD
Omeprazole—Headache—Capecitabine—colon cancer	8.46e-05	0.000609	CcSEcCtD
Omeprazole—Feeling abnormal—Methotrexate—colon cancer	8.28e-05	0.000596	CcSEcCtD
Omeprazole—Gastrointestinal pain—Methotrexate—colon cancer	8.22e-05	0.000591	CcSEcCtD
Omeprazole—Nausea—Capecitabine—colon cancer	8.02e-05	0.000577	CcSEcCtD
Omeprazole—Urticaria—Methotrexate—colon cancer	7.98e-05	0.000575	CcSEcCtD
Omeprazole—Body temperature increased—Methotrexate—colon cancer	7.94e-05	0.000572	CcSEcCtD
Omeprazole—Abdominal pain—Methotrexate—colon cancer	7.94e-05	0.000572	CcSEcCtD
Omeprazole—Hypersensitivity—Methotrexate—colon cancer	7.4e-05	0.000533	CcSEcCtD
Omeprazole—Asthenia—Methotrexate—colon cancer	7.21e-05	0.000519	CcSEcCtD
Omeprazole—Pruritus—Methotrexate—colon cancer	7.11e-05	0.000512	CcSEcCtD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	6.9e-05	0.00389	CbGpPWpGaD
Omeprazole—Diarrhoea—Methotrexate—colon cancer	6.88e-05	0.000495	CcSEcCtD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor—NRAS—colon cancer	6.81e-05	0.00384	CbGpPWpGaD
Omeprazole—Dizziness—Methotrexate—colon cancer	6.64e-05	0.000478	CcSEcCtD
Omeprazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	6.51e-05	0.00368	CbGpPWpGaD
Omeprazole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	6.48e-05	0.00366	CbGpPWpGaD
Omeprazole—Vomiting—Methotrexate—colon cancer	6.39e-05	0.00046	CcSEcCtD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor—MYC—colon cancer	6.34e-05	0.00358	CbGpPWpGaD
Omeprazole—Rash—Methotrexate—colon cancer	6.34e-05	0.000456	CcSEcCtD
Omeprazole—Dermatitis—Methotrexate—colon cancer	6.33e-05	0.000456	CcSEcCtD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	6.33e-05	0.00357	CbGpPWpGaD
Omeprazole—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	6.3e-05	0.00355	CbGpPWpGaD
Omeprazole—Headache—Methotrexate—colon cancer	6.29e-05	0.000453	CcSEcCtD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	6.21e-05	0.0035	CbGpPWpGaD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—colon cancer	6.21e-05	0.0035	CbGpPWpGaD
Omeprazole—ABCG2—Fluoropyrimidine Activity—TP53—colon cancer	6.18e-05	0.00349	CbGpPWpGaD
Omeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	6.17e-05	0.00348	CbGpPWpGaD
Omeprazole—Nausea—Methotrexate—colon cancer	5.97e-05	0.00043	CcSEcCtD
Omeprazole—CYP1B1—Metabolism—CA7—colon cancer	5.95e-05	0.00336	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—colon cancer	5.94e-05	0.00335	CbGpPWpGaD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor—KRAS—colon cancer	5.86e-05	0.00331	CbGpPWpGaD
Omeprazole—CYP11A1—Corticotropin-releasing hormone—TGFB1—colon cancer	5.7e-05	0.00322	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—ODC1—colon cancer	5.65e-05	0.00319	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—CHST5—colon cancer	5.65e-05	0.00319	CbGpPWpGaD
Omeprazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	5.56e-05	0.00314	CbGpPWpGaD
Omeprazole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	5.49e-05	0.0031	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CA7—colon cancer	5.41e-05	0.00305	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	5.39e-05	0.00304	CbGpPWpGaD
Omeprazole—CYP1A1—Arachidonic acid metabolism—PTGS2—colon cancer	5.04e-05	0.00285	CbGpPWpGaD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—colon cancer	4.98e-05	0.00281	CbGpPWpGaD
Omeprazole—ABCG2—HIF-1-alpha transcription factor network—EP300—colon cancer	4.96e-05	0.0028	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—CHST5—colon cancer	4.89e-05	0.00276	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—ODC1—colon cancer	4.89e-05	0.00276	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	4.8e-05	0.00271	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—ODC1—colon cancer	4.76e-05	0.00268	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—CHST5—colon cancer	4.76e-05	0.00268	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	4.71e-05	0.00266	CbGpPWpGaD
Omeprazole—ABCG2—HIF-1-alpha transcription factor network—VEGFA—colon cancer	4.7e-05	0.00265	CbGpPWpGaD
Omeprazole—CYP2C8—Arachidonic acid metabolism—PTGS2—colon cancer	4.62e-05	0.00261	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	4.48e-05	0.00253	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—EP300—colon cancer	4.48e-05	0.00253	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	4.36e-05	0.00246	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—SRC—colon cancer	4.36e-05	0.00246	CbGpPWpGaD
Omeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	4.29e-05	0.00242	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	4.25e-05	0.0024	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—colon cancer	4.19e-05	0.00237	CbGpPWpGaD
Omeprazole—CYP2C19—Arachidonic acid metabolism—PTGS2—colon cancer	4.13e-05	0.00233	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	4.04e-05	0.00228	CbGpPWpGaD
Omeprazole—CYP11A1—Corticotropin-releasing hormone—AKT1—colon cancer	3.96e-05	0.00224	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—colon cancer	3.91e-05	0.00221	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	3.9e-05	0.0022	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—colon cancer	3.82e-05	0.00216	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	3.82e-05	0.00216	CbGpPWpGaD
Omeprazole—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	3.76e-05	0.00212	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CA7—colon cancer	3.66e-05	0.00207	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—colon cancer	3.61e-05	0.00204	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—ODC1—colon cancer	3.6e-05	0.00203	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—CHST5—colon cancer	3.6e-05	0.00203	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	3.44e-05	0.00194	CbGpPWpGaD
Omeprazole—CYP1A1—PPARA activates gene expression—PPARG—colon cancer	3.41e-05	0.00193	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CA7—colon cancer	3.36e-05	0.0019	CbGpPWpGaD
Omeprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—colon cancer	3.34e-05	0.00188	CbGpPWpGaD
Omeprazole—ABCC3—NRF2 pathway—TGFB1—colon cancer	3.31e-05	0.00187	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CHST5—colon cancer	3.28e-05	0.00185	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—ODC1—colon cancer	3.28e-05	0.00185	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	3.23e-05	0.00182	CbGpPWpGaD
Omeprazole—CYP1A2—Arachidonic acid metabolism—PTGS2—colon cancer	3.22e-05	0.00181	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—colon cancer	3.07e-05	0.00173	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	3e-05	0.0017	CbGpPWpGaD
Omeprazole—ABCG2—HIF-1-alpha transcription factor network—AKT1—colon cancer	3e-05	0.00169	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CA7—colon cancer	3e-05	0.00169	CbGpPWpGaD
Omeprazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	2.97e-05	0.00167	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CA7—colon cancer	2.93e-05	0.00165	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	2.86e-05	0.00161	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—EP300—colon cancer	2.86e-05	0.00161	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	2.78e-05	0.00157	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—SRC—colon cancer	2.78e-05	0.00157	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CA7—colon cancer	2.76e-05	0.00156	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CA7—colon cancer	2.73e-05	0.00154	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	2.71e-05	0.00153	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—ABCB1—colon cancer	2.68e-05	0.00151	CbGpPWpGaD
Omeprazole—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	2.68e-05	0.00151	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	2.67e-05	0.00151	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—CASP3—colon cancer	2.59e-05	0.00146	CbGpPWpGaD
Omeprazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	2.54e-05	0.00143	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—colon cancer	2.49e-05	0.00141	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	2.49e-05	0.0014	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	2.47e-05	0.0014	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	2.44e-05	0.00138	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	2.44e-05	0.00138	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	2.38e-05	0.00134	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CA7—colon cancer	2.34e-05	0.00132	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.33e-05	0.00132	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	2.3e-05	0.0013	CbGpPWpGaD
Omeprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	2.3e-05	0.0013	CbGpPWpGaD
Omeprazole—CYP1A1—PPARA activates gene expression—EP300—colon cancer	2.23e-05	0.00126	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CHST5—colon cancer	2.22e-05	0.00125	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ODC1—colon cancer	2.22e-05	0.00125	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—VEGFA—colon cancer	2.2e-05	0.00124	CbGpPWpGaD
Omeprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	2.18e-05	0.00123	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CHST5—colon cancer	2.03e-05	0.00115	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ODC1—colon cancer	2.03e-05	0.00115	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—TGFB1—colon cancer	2.02e-05	0.00114	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.96e-05	0.00111	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	1.96e-05	0.0011	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—ABCB1—colon cancer	1.85e-05	0.00104	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.83e-05	0.00104	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CHST5—colon cancer	1.82e-05	0.00103	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ODC1—colon cancer	1.82e-05	0.00103	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	1.82e-05	0.00102	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CA7—colon cancer	1.8e-05	0.00102	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ODC1—colon cancer	1.77e-05	0.001	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CHST5—colon cancer	1.77e-05	0.001	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CHST5—colon cancer	1.67e-05	0.000943	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ODC1—colon cancer	1.67e-05	0.000943	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ODC1—colon cancer	1.66e-05	0.000935	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CHST5—colon cancer	1.66e-05	0.000935	CbGpPWpGaD
Omeprazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	1.62e-05	0.000915	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.54e-05	0.000872	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.53e-05	0.000861	CbGpPWpGaD
Omeprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	1.51e-05	0.00085	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—ABCB1—colon cancer	1.49e-05	0.000843	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.49e-05	0.00084	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—TYMS—colon cancer	1.47e-05	0.000828	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ODC1—colon cancer	1.42e-05	0.000799	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CHST5—colon cancer	1.42e-05	0.000799	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.38e-05	0.000778	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—ABCB1—colon cancer	1.29e-05	0.000729	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.28e-05	0.000725	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.28e-05	0.000722	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—TYMS—colon cancer	1.27e-05	0.000716	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—ABCB1—colon cancer	1.26e-05	0.000709	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.25e-05	0.000703	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—TYMS—colon cancer	1.23e-05	0.000697	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.23e-05	0.000696	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.2e-05	0.00068	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.17e-05	0.000661	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.15e-05	0.000647	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.13e-05	0.000637	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.11e-05	0.000629	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ODC1—colon cancer	1.09e-05	0.000616	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CHST5—colon cancer	1.09e-05	0.000616	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.09e-05	0.000613	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PPARG—colon cancer	1.04e-05	0.000586	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	9.99e-06	0.000564	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	9.97e-06	0.000563	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	9.77e-06	0.000552	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	9.73e-06	0.000549	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—ABCB1—colon cancer	9.52e-06	0.000537	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	9.5e-06	0.000536	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—TYMS—colon cancer	9.35e-06	0.000528	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	9.23e-06	0.000521	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.16e-06	0.000517	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PPARG—colon cancer	8.99e-06	0.000507	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PPARG—colon cancer	8.74e-06	0.000493	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—ABCB1—colon cancer	8.66e-06	0.000489	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—TYMS—colon cancer	8.51e-06	0.00048	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	8.48e-06	0.000479	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.4e-06	0.000474	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	8.21e-06	0.000463	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PTGS2—colon cancer	8.17e-06	0.000461	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	7.5e-06	0.000423	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.21e-06	0.000407	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	7.2e-06	0.000406	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PTGS2—colon cancer	7.07e-06	0.000399	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	6.93e-06	0.000391	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PTGS2—colon cancer	6.88e-06	0.000388	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	6.84e-06	0.000386	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—EP300—colon cancer	6.8e-06	0.000384	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PPARG—colon cancer	6.63e-06	0.000374	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.61e-06	0.000373	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PPARG—colon cancer	6.03e-06	0.00034	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.99e-06	0.000338	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.9e-06	0.000333	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—EP300—colon cancer	5.88e-06	0.000332	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ABCB1—colon cancer	5.86e-06	0.000331	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.84e-06	0.00033	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—TYMS—colon cancer	5.76e-06	0.000325	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—EP300—colon cancer	5.72e-06	0.000323	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.5e-06	0.00031	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.38e-06	0.000304	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ABCB1—colon cancer	5.38e-06	0.000303	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—TYMS—colon cancer	5.28e-06	0.000298	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTGS2—colon cancer	5.21e-06	0.000294	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PIK3CA—colon cancer	5.03e-06	0.000284	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.91e-06	0.000277	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ABCB1—colon cancer	4.8e-06	0.000271	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTGS2—colon cancer	4.74e-06	0.000268	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—TYMS—colon cancer	4.71e-06	0.000266	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—TYMS—colon cancer	4.6e-06	0.00026	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.6e-06	0.000259	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.47e-06	0.000252	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.43e-06	0.00025	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ABCB1—colon cancer	4.41e-06	0.000249	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ABCB1—colon cancer	4.38e-06	0.000247	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PIK3CA—colon cancer	4.35e-06	0.000245	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—TYMS—colon cancer	4.34e-06	0.000245	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—EP300—colon cancer	4.33e-06	0.000245	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—TYMS—colon cancer	4.3e-06	0.000243	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PIK3CA—colon cancer	4.23e-06	0.000239	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—AKT1—colon cancer	4.11e-06	0.000232	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PPARG—colon cancer	4.08e-06	0.00023	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.07e-06	0.000229	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—EP300—colon cancer	3.94e-06	0.000223	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.82e-06	0.000216	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PPARG—colon cancer	3.74e-06	0.000211	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ABCB1—colon cancer	3.74e-06	0.000211	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—TYMS—colon cancer	3.67e-06	0.000207	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.63e-06	0.000205	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—AKT1—colon cancer	3.55e-06	0.000201	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—AKT1—colon cancer	3.46e-06	0.000195	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PPARG—colon cancer	3.34e-06	0.000188	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.31e-06	0.000187	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PPARG—colon cancer	3.26e-06	0.000184	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTGS2—colon cancer	3.21e-06	0.000181	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CA—colon cancer	3.21e-06	0.000181	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PPARG—colon cancer	3.07e-06	0.000173	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PPARG—colon cancer	3.04e-06	0.000172	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTGS2—colon cancer	2.94e-06	0.000166	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CA—colon cancer	2.92e-06	0.000165	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ABCB1—colon cancer	2.89e-06	0.000163	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—TYMS—colon cancer	2.83e-06	0.00016	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.83e-06	0.00016	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—EP300—colon cancer	2.67e-06	0.000151	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTGS2—colon cancer	2.63e-06	0.000148	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—AKT1—colon cancer	2.62e-06	0.000148	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PPARG—colon cancer	2.6e-06	0.000147	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTGS2—colon cancer	2.56e-06	0.000145	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—EP300—colon cancer	2.45e-06	0.000138	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTGS2—colon cancer	2.42e-06	0.000136	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTGS2—colon cancer	2.4e-06	0.000135	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—AKT1—colon cancer	2.38e-06	0.000135	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—EP300—colon cancer	2.18e-06	0.000123	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—EP300—colon cancer	2.13e-06	0.00012	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTGS2—colon cancer	2.05e-06	0.000116	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—EP300—colon cancer	2.01e-06	0.000113	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PPARG—colon cancer	2.01e-06	0.000113	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—EP300—colon cancer	1.99e-06	0.000112	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CA—colon cancer	1.97e-06	0.000111	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CA—colon cancer	1.81e-06	0.000102	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—EP300—colon cancer	1.7e-06	9.61e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CA—colon cancer	1.62e-06	9.12e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—AKT1—colon cancer	1.61e-06	9.1e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTGS2—colon cancer	1.58e-06	8.91e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CA—colon cancer	1.58e-06	8.9e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CA—colon cancer	1.49e-06	8.39e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—AKT1—colon cancer	1.48e-06	8.35e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CA—colon cancer	1.47e-06	8.32e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—AKT1—colon cancer	1.32e-06	7.45e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—EP300—colon cancer	1.31e-06	7.41e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—AKT1—colon cancer	1.29e-06	7.27e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CA—colon cancer	1.26e-06	7.11e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—AKT1—colon cancer	1.21e-06	6.85e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—AKT1—colon cancer	1.2e-06	6.79e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—AKT1—colon cancer	1.03e-06	5.81e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CA—colon cancer	9.72e-07	5.48e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AKT1—colon cancer	7.94e-07	4.48e-05	CbGpPWpGaD
